Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Migraine Market Gets Competitive With Second, Third CGRP Inhibitor Launches

Nov 10 2018

• By Mandy Jackson

Migraine word written on wood block

Related Content

Amgen Focuses On Pipeline As Mature Products Face Declining Demand

Oct 26 2017

Response Rates Rule In CGRP Inhibitor Migraine Studies

Jun 12 2017

Phase III Lasmiditan Data Strengthens Lilly's Dual Migraine Strategy

Aug 05 2017

Can Lilly’s Cluster Headache Data Differentiate Its CGRP Inhibitor?

May 15 2018

Amgen's Aimovig Aims To Capture As Many Migraine Patients As Possible With $6,900 Price

May 18 2018

Teva Stands By Migraine Strategy After Ajovy Misses Boat On Express Scripts Deal

Oct 18 2018

Allergan's Ubrogepant Succeeds In Second Acute Migraine Phase III Study

Apr 28 2018

Is Quarterly Dosing For Teva's Ajovy Enough To Differentiate It From Other CGRP Inhibitors?

Sep 18 2018

Lilly Looks To Emgality Access, Injector And Data To Differentiate Its CGRP Inhibitor

Sep 29 2018

Lilly Moves Into Migraine Race With CHMP Okay

Sep 24 2018

Teva: No Reason To "Panic" When It Comes To Ajovy Access

Nov 01 2018

Teva's CGRP Inhibitor Fails In Chronic Cluster Headaches, Continues In Episodic

Jun 15 2018

Migraine Drug Atogepant Delivers Good News When Allergan Needs It Most

Jun 11 2018

Deal Watch: Ionis Turns To Affiliate Akcea In Amyloidosis

Mar 15 2018

Biohaven Posts Positive Migraine Results, But Investors Are Wary

Mar 27 2018

Allergan migraine portfolio grows with Merck CGRP antagonists

Jul 08 2015

Related Companies

Amgen, Inc.

Novartis AG

Teva Pharmaceutical Industries Ltd.

Eli Lilly and Company

Express Scripts Holding Company

Allergan plc

Alder Biopharmaceuticals, Inc.

Anthem Inc.

Merck & Co., Inc.

Biohaven Pharmaceutical Holding Company Ltd.

Bristol Myers Squibb Company

Additional Topics

Launches Sales & Earnings Market Access Reimbursement Strategy Commercial Neurology BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window